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Adverse drug reactions (ADRs) are as important in 
psychiatric practice as they are in any other branch of 
medicine. The safety of medicines is an essential part of 
patient safety. Global drug safety depends on strong 
national systems that monitor the development and 
quality of medicines, report their harmful effects, and 
provide accurate information for their safe use. ADRs are 
defined as an „unexpected, unintended, undesired or 
excessive response to a drug‟, which would include 
„allergic reactions and idiosyncratic reactions that are an 
abnormal susceptibility to a drug peculiar to the 
individual‟.1 All noxious and unintended responses to a 
medicinal product related to any dose should be 
considered adverse drug reaction.2 ADRs only affect a 
minority of those taking a particular drug. It is often seen 
that commonly prescribed drugs, elicit ADR in some, at 
the same time many remain unaffected. 
Pharmacovigilance is, “The Pharmacological Science 
relating to the detection, assessment, understanding and 
prevention of adverse effects, particularly long term and 
short term side effects of medicines.”3 
Pharmacovigilance in psychiatry units can play a vital 
role in detecting ADRs and alerting physicians to the 
possibility and circumstances of such events, thereby 
protecting the user population from avoidable harm.4 
Many psychotropic drugs are available in India and their 
use is increasing day by day. Commonly used 
psychotropic drugs in psychiatry O.P.D. are the drugs 
used for psychoses, depression, epilepsy, mania, 
migraine and insomnia. These drugs are capable of 
causing a number of ADRs,
5,6
 some of which may be 
fatal. Most commonly ADRs are seen with 
antipsychotics and mood stabilizers. ADRs associated 
with psychotropic drugs can lead to  noncompliance, and 
at times discontinuation of therapy.7 In India, 
pharmacovigilance activities are still in the nascent stage 
and the data of ADRs particularly related to psychotropic 
drugs need  to be strengthened.8 
Objectives: 
 To determine the incidence of ADRs and to 
assess the causality of ADRs in psychiatry O.P.D. at our 
tertiary care teaching hospital. 
MATERIALS AND METHODS: 
 A longitudinal observational study was carried 
out at our psychiatry out-patient-department (OPD) in a 
tertiary care teaching hospital. This hospital caters to the 
health care needs of thousands of patients from 
Surendranagar city, many villages and town around the 
city. It was part of ongoing pharmacovigilance activity at 
the Institute which had the necessary administrative and 
Institutional Ethics Committee (IEC) clearance. 
 The data was collected prospectively of the 
patients reporting to psychiatry OPD. The study was 
carried out for 3 months between May 2012 and July 
2012. Out of 4169 patients attending to psychiatry OPD 
within these 3 months, the patients with ADRs were 
evaluated. Diagnosis of ADR was made by psychiatrist. 
All the doctors, residents, interns, and nursing staff were 
informed to notify any suspected ADRs. Patient details 
(age, sex, body weight), adverse event history, history of 
medication suspected of having caused the ADR, and 
details of concomitant medication use were recorded in 
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the format followed in the Indian National 
Pharmacovigilance Programme.9 Causality of the event 
was assessed by World Health Organization-Uppsala 
Monitoring Centre (WHO-UMC) criteria.10] Suspected 
ADRs with causality status less than "possible" were 
excluded from the study. 
 
RESULTS: 
 A total of 4169 patients observed for the study, out of which 28 (0.67%) were diagnosed as having at least one 
ADR, diagnosed by psychiatrist. A total of 43 ADRs were noted from 15 psychotropic drugs.   
Table 1: Age & Sex wise distribution of ADRs 
Table 1 shows that most common age group is 25-40 years (46.42%) with female preponderance only in age group 40-
55 years.  In other age groups, male preponderance is seen.  Median age was 40 years. It also shows that total no. of 
males (64.28%) are having more ADRs than female (35.71%). 
 
Table 2:  Various types of ADRs and no. of them 
Table 2 displays that maximum number of ADRs seen is nausea, which is 9(20.93%) in number and is followed by 
weight gain (11.63%). Severe ADR like seizure is seen only in 1(2.32%) case which was due to Amitriptyline.  
 
Table 3: Various groups of drugs causing ADRs 
Table 3 shows that most common group of drug causing ADRs is Anti-depressant drugs (41.86%) followed by anti-
epileptic drugs (27.90%). And least common is with drugs for migraine (2.43%). 
 
 
Sr. No. Age Group ( in years) No. of Male patients No. of Female patients Total no. of patients 
1. < 25  3 0 3 
2. 25-40 9 4 13 
3. 40-55 2 5 7 
4. >55 4 1 5 
 Total 18 10 28 
Type   of  ADRs Drugs  causing  ADRs No. of 
ADRs  
Hypersomnia Gabapentin, Clozapine, Venlafexine, Alprazolam 4 
Dizziness Gabapentin, Alprazolam 2 
Headache Ethosuximide, Duloxetine, Escitalopram, Alprazolam 4 
Drowsiness Ethosuximide, Escitalopram, Alprazolam 3 
Skin Rashes Phenytoin(2), Carbamazepine, Clozapine 4 
Gingivial  swelling Phenytoin 1 
Weight  gain Valproate, Olanzapine, Amitriptyline(2), Olanzapine 5 
Nausea Valproate, Carbamazepine, Venlafexine, Duloxetine(3) Escitalopram(2), Lithium 9 
Vomiting Carbamazepine,  Sertaline,  Duloxetine 3 
Diarrhea Sertaline(2) 2 
Jaundice  Haloperidol 1 
Seizures Amitriptyline 1 
Insomnia Duloxetine 1 
Decrease frequency of  
micturition 
Amitriptyline 1 
Tremors Lithium,  Haloperidol 2 
Group of drugs Name of drugs No. of ADRs observed 
Anti-epileptic  drugs Phenytoin,  Ethosuximide, Carbamazepine,  Valproate, Gabapentin  12 
Anti-psychotic drugs Clozapine,  Olanzapine, Haloperidol 6 
Anti-depressant drugs Duloxetine,  Escitalopram, Amitripyline,  Sertaline, Venlafexine 18 
Anti-manic drugs Lithium 2 
Sedative & Hypnotics Alprazolam 4 
Drugs for Migraine Amitriptyline 1 
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Table 4:  Various ADRs on Causality assessment scale 
Sr. No. Causality  assessment No.  of  patients  Percent 
1. Certain 4 14.28 
2. Probable 12 42.85 
3. Possible 12 42.85 
 
Table 4 displays that there is an equal number of patients 
for probable and possible analysis observed. 4 cases of 
Phenytoin, Escitalopram, Duloxetine and Alprazolam 
were rechallanged and ADR reappeared so they were 
included in certain criteria of WHO scale. Cases who had 
insufficient evidence about causality (WHO-UMC 
causality status "unlikely" or less than that) were 
excluded from further analysis. 
DISCUSSION:  
 Present study has been done to report the 
incidence of ADRs to psychotropic drugs in the 
psychiatry OPD setting in the tertiary care hospital. A 
knowledge, practice and attitude based study conducted 
in Norway found that ADRs can be prevented by 
collecting reliable information about their frequencies 
and possible risk factors.[11] Among all the ADRs 
reported, maximum number of ADRs are seen with anti-
depressant drugs. G.I. symptoms, headache and sexual 
effects are most common side effects seen with SSRIs 
and SNRI.[12] Newer generation Escitalopram and 
Duloxetine are most commonly prescribed anti-
depressant drugs in our hospital. In our study, Duloxetine 
is the most common drug causing ADR. Sengupta et al., 
in their study [8] - find that Olanzapine is the most 
common drug causing ADRs.8 
 The other common groups of drugs causing 
ADRs in our study are anti-epileptic drugs and anti-
psychotic drugs. Sengupta et al., in their study8 - find that 
anti-psychotic drugs are the most common group of 
drugs causing ADRs. Common side-effects with anti-
epileptic drugs that affect people include unsteadiness 
and sleepiness. Side-effects often happen when you start 
taking a new anti-epileptic drug, or if the dose is too 
high.13 In our study, Phenytoin and Carbamazepine are 
causing maximum side effects. Conventional or “typical" 
antipsychotics (e.g., Haloperidol etc.) were prescribed 
with associated limitations of poor efficacy against 
negative symptoms and unwanted Extra Pyramidal 
Symptoms (EPS), particularly at higher doses.14,15,16 In 
our study, haloperidol is causing tremors and jaundice. 
Over the last few years, atypical antipsychotics 
(e.g.,Clozapine, Olanzapine etc.) have been increasingly 
used in the pharmacological treatment of schizophrenia 
and other related psychotic disorders. Atypical 
antipsychotics differ from conventional agents in that 
they have lower risk of EPS and significantly reduce 
both positive and negative symptoms of schizophrenia.18 
In our study, Olanzapine is causing weight gain and no 
any other ADRs. 
 In our study, most common ADR found was 
nausea followed by weight gain. Drug induced seizures, 
tremors and decreased frequency of micturition were rare 
findings. 
Weight gain: 
 Weight gain is associated with the use of many 
psychotropic medications, including antidepressants, 
mood stabilizers, antipsychotic drugs, and may have 
serious long term consequences.17  Tricyclic 
Antidepressants (TCA) induced weight  gain correlated 
positively with dosage and duration of treatment, more 
pronounced with Amitriptyline; Selective Serotonin  
Reuptake Inhibitors (SSRIs) decrease transiently body 
weight during the first few weeks of treatment and may 
then increase body weight; weight gain appears to be 
most prominent with some mood stabilizers 
(Lithium,Valproate); atypical antipsychotics tend to 
cause more weight gain than  conventional one, seems to 
be more severe with Clozapine and Olanzapine.18 This 
supports our study as in our study, weight gain is 
produced by Amitriptyline, Valproate and Olanzapine. 
Drug induced tremors: 
 A drug-induced tremor is involuntary shaking 
due to the use of medication. Drugs that can cause 
tremors are mood stabilizer (Lithium), anti-convulsant 
(Valproate) and others. Tremors are mostly relieved after 
stopping the drug. In rare cases, a drug such as 
Propanalol or Primidone may be added to help control 
the tremor. Here, in our study tremors are produced by 
Lithium (Anti-manic drug) and Haloperidol (Typical-
antipsychotic drugs).  
Drug induced seizures:  
 Seizure threshold is lowered with anti-
depressant drugs, so fits may be precipitated, especially 
in children. TCAs have greater propensity while SSRI 
and SNRI are safe in this regard. In our study, 
Amitriptyline, a tricyclic anti-depressant is causing drug 
induced seizures in a twenty three year old boy. 
Decrease frequency of micturition: 
 Anti-depressant drugs are having anti-
cholinergic effect. Anticholinergic effects appear most 
frequently and cause the greatest morbidity in geriatric 
patients. It causes urinary retention, especially in elderly 
male patient with enlarged prostate. In our study one 
case of urinary retention was noted with Amitriptyline.  
CONCLUSION 
 This study gives a representative profile of 
ADRs to be expected in psychiatry out-patient in an 
Indian Tertiary care teaching hospital. Establishment of a 
psychotropic drug ADR database can be a worthy long-
term goal in the Indian context. 
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